ibogaine has been researched along with isomethyleugenol in 2 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (isomethyleugenol) | Trials (isomethyleugenol) | Recent Studies (post-2010) (isomethyleugenol) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 33,847 | 127 | 11,831 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hearn, WL; Hime, GW; Mash, DC; Pablo, J | 1 |
| Mash, DC; Obach, RS; Pablo, J | 1 |
2 other study(ies) available for ibogaine and isomethyleugenol
| Article | Year |
|---|---|
Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry.
Topics: Administration, Oral; Animals; Brain; Calibration; Chlorocebus aethiops; Dimethyl Sulfoxide; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; Ibogaine; Macaca fascicularis; Methylation; Netherlands; Reference Standards; Reproducibility of Results | 1995 |
Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine.
Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Hallucinogens; Humans; Ibogaine; Isoenzymes; Kinetics; Methylation; Microsomes, Liver | 1998 |